- Home
- BIOR vs AWH Comparison
BIOR vs AWH Comparison
Compare BIOR & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOR
- AWH
- Stock Information
- Founded
- BIOR 2010
- AWH 1993
- Country
- BIOR United States
- AWH United States
- Employees
- BIOR N/A
- AWH N/A
- Industry
- BIOR Biotechnology: Pharmaceutical Preparations
- AWH Medical/Dental Instruments
- Sector
- BIOR Health Care
- AWH Health Care
- Exchange
- BIOR Nasdaq
- AWH Nasdaq
- Market Cap
- BIOR 12.6M
- AWH 13.5M
- IPO Year
- BIOR 2020
- AWH N/A
- Fundamental
- Price
- BIOR $2.12
- AWH $0.75
- Analyst Decision
- BIOR Strong Buy
- AWH Buy
- Analyst Count
- BIOR 1
- AWH 2
- Target Price
- BIOR $150.00
- AWH $4.40
- AVG Volume (30 Days)
- BIOR 121.2K
- AWH 139.7K
- Earning Date
- BIOR 11-14-2024
- AWH 11-14-2024
- Dividend Yield
- BIOR N/A
- AWH N/A
- EPS Growth
- BIOR N/A
- AWH N/A
- EPS
- BIOR N/A
- AWH N/A
- Revenue
- BIOR $892,000.00
- AWH $8,923,000.00
- Revenue This Year
- BIOR $32,550.00
- AWH $15.56
- Revenue Next Year
- BIOR $95.48
- AWH $105.32
- P/E Ratio
- BIOR N/A
- AWH N/A
- Revenue Growth
- BIOR 4855.56
- AWH N/A
- 52 Week Low
- BIOR $2.03
- AWH $0.72
- 52 Week High
- BIOR $19.90
- AWH $5.65
- Technical
- Relative Strength Index (RSI)
- BIOR 25.71
- AWH 33.23
- Support Level
- BIOR $2.44
- AWH $0.84
- Resistance Level
- BIOR $3.10
- AWH $0.87
- Average True Range (ATR)
- BIOR 0.36
- AWH 0.09
- MACD
- BIOR -0.03
- AWH -0.02
- Stochastic Oscillator
- BIOR 4.95
- AWH 12.87
About BIOR Biora Therapeutics Inc.
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.